期刊文献+

D-二聚体、B型钠尿肽与血气在慢性阻塞性肺疾病继发肺栓塞的预测价值 被引量:12

Predictive value of D-dimer,B-type natriuretic peptide and blood gas indexes in risk of secondary pulmonary thromboembolism in patients with chronic obstructive pulmonary disease
原文传递
导出
摘要 目的探讨血浆D-二聚体、B型钠尿肽和血气(PaO 2、PaCO 2)在高风险慢性阻塞性肺疾病急性加重期(AECOPD)继发肺栓塞(PTE)的预测价值。方法选取于2016年1月至2017年12月期间在我院住院的32例高风险AECOPD继发PTE的患者作为血栓组;同期住院60例高风险AECOPD未继发PTE的患者为高风险单纯COPD组;另选择同期住院的52例低风险AECOPD(未继发PTE)患者为低风险COPD组。对所有入选的患者行血浆D-二聚体、B型钠尿肽(BNP)及血气分析检查并进行对比分析。结果高风险AECOPD患者(血栓组和高风险单纯COPD组)的血浆D-二聚体、BNP的均值均高于低风险COPD组患者,血栓组患者血浆D-二聚体均值又高于高风险单纯COPD组患者,差异均具有统计学意义(P<0.05)。血栓组患者的PaCO 2及PaO 2均值均低于高风险单纯COPD组及低风险COPD组患者,差异均具有统计学意义(P<0.05)。高风险单纯COPD组患者PaCO 2高于低风险COPD组患者(P<0.05),但两组间PaO 2均值差异无统计学意义。结论高风险AECOPD患者的血浆D-二聚体、BNP水平升高,低氧血症、二氧化碳潴留,继发肺栓塞时,D-二聚体及BNP升高更明显,低氧进一步加重,且在原有高二氧化碳水平的基础上出现PaCO 2下降,均值>5 mmHg,提示血浆D-二聚体、BNP与血气分析检测在判断高风险AECOPD继发肺栓塞的风险中有较高的预测价值,能为临床及时判断高风险AECOPD患者早期抗凝治疗提供重要的依据。 Objective To investigate the predictive value of plasma D-dimmer,B-type natriuretic peptide(BNP)and blood gas indexes in secondary pulmonary thromboembolism(PTE)during the high-risk of acute exacerbation of chronic obstructive pulmonary disease(AECOPD).Methods A total of 32 patients with high-risk AECOPD+secondary PTE,treated in our hospital from January 2016 to December 2017,were collected as the thrombosis group,60 patients with high-risk of AECOPD without secondary PTE,treated at the same period,were selected as the simple high-risk COPD group,and 52 patients with low-risk COPD during the period of acute exacerbation(without secondary PTE),treated at the same period,were selected as the low-risk COPD group.The plasma D-dimmer,BNP,and blood gas indexes[the arterial partial pressure of oxygen(PaO 2)and the arterial partial pressure of carbon dioxide(PaCO 2)]were detected and analyzed in all the patients.Results The mean values of plasma D-dimmer and BNP in the thrombosis group and the simple high-risk COPD group were higher than those of the low-risk COPD group.The mean value of plasma D-dimmer in the thrombosis group was higher than that of the high-risk COPD group,and statistical significant differences were found between the two groups(P<0.05).The PaCO 2 and PaO 2 in the thrombosis group were lower than those of the simple high-risk COPD group and the low-risk COPD group,and statistical significant differences were found between the two groups(P<0.05).The patients with simple high-risk COPD had higher PaCO 2 than the patients with low-risk COPD(P<0.05),however,there was no statistical significant difference in the mean PaO 2 between the two groups.Conclusion In the patients with high-risk AECOPD,the plasma D-dimmer and BNP levels are elevated,and hypoxemia and carbon dioxide retention occur.When combined with pulmonary thromboembolism,the D-dimmer and BNP levels increase more significantly,the symptoms of hypoxia are further aggravated.And on the basis of original high carbon dioxide,there is a decrease in the PaCO 2,with a mean value greater than 5 mm Hg,suggesting that the plasma D-dimmer,BNP,and blood gas analysis tests have a good predictive value in judging the high-risk AECOPD associated with pulmonary embolism.It can provide an important basis for early clinical anticoagulant therapy for the patients with acute exacerbation of high-risk COPD.
作者 吴文彬 陈昌枝 杨冬莲 覃家盟 冯洁美 Wu Wenbin;Cheng Changzhi;Yang Donglian;Qin Jiameng;Feng Jiemei(Department of Respiratory Medicine,Guigang People′s Hospital&Eighth Affiliated Hospital of Guangxi Medical University,Guigang 537100,China;Center of Vision,Guigang People′s Hospital&Eighth Affiliated Hospital of Guangxi Medical University,Guigang 537100,China)
出处 《中华肺部疾病杂志(电子版)》 CAS 2019年第6期743-746,共4页 Chinese Journal of Lung Diseases(Electronic Edition)
关键词 肺疾病 慢性阻塞性 肺栓塞 血浆D-二聚体 B型钠尿肽 血气分析 Chronic obstructive pulmonary disease Pulmonary embolism D-dimmer B-type natriuretic peptide Blood gas analysis
  • 相关文献

参考文献8

二级参考文献57

  • 1俞森洋.慢性阻塞性肺病和哮喘的雾化吸入疗法[J].中国药物应用与监测,2006,3(4):28-31. 被引量:11
  • 2杨伟敏,陈红.肺炎衣原体感染对慢性阻塞性肺疾病患者细胞免疫功能的影响[J].中国实用内科杂志,2006,26(7):992-994. 被引量:5
  • 3Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet, 1999,353 : 1386-1389.
  • 4Coutance G, Le PO, Lo T, et al. Prognostic value of brain natriuretic peptide in acute pulmonary embolism. Crit Care, 2008, 12 :R109.
  • 5Kurose M, Yoshimura M, Yasue H. Raised plasma BNP in a patient with acute pulmonary thromboembolism. Heart, 1997,78 : 320 -321.
  • 6Kruger S, Graf J, Merx MW, et al. Brain natriuretic peptide predicts right heart failure in patients with acute pulmonary embolism. Am Heart J, 2004,147:60-65.
  • 7Logeart D, Lecuyer L, Thabut G, et al. Biomarker-based strategy for screening right ventricular dysfunction in patients with non- massive pulmonary embolism. Intensive Care Med, 2007,33:286- 292.
  • 8Kucher N, Printzen G, Goldhaber SZ. Prognostic role of brain natriuretic peptide in acute pulmonary embolism. Circulation, 2003,107:2545-2547.
  • 9British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax, 2003,58:470-483.
  • 10慢性阻塞性肺疾病急性加重患者的机械通气指南(2007)[J].中国危重病急救医学,2007,19(9):513-518. 被引量:333

共引文献1855

同被引文献120

引证文献12

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部